News Posts List
Use of gene expression profiling to predict survival in cancer
07/06/2010
Duplicated 1q might be a secondary mutations associated with disease progression. Trisomy of 1q has also been linked to metastatic potential of colon and renal cell carcinomas.
RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma
07/06/2010
Vascular endothelial growth factors (VEGFs) are crucial regulators of angiogenesis and vasculogenesis.
Charity Navigator: Kidney Cancer Association
07/04/2010
Founded in 1990, the Kidney Cancer Association (KCA) is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. We fund, promote, and collaborate with the National Cancer Institute, American Society for Clinical Oncology, American Urological Association, and other institutions on research projects
Concurrent Multilocular Cystic Renal Cell Carcinoma and Leiomyoma in the Same Kidney
07/04/2010
This is the first report of this kind of presentation.
Bone metastases from renal cell carcinoma: patient survival after surgical treatment
07/04/2010
Surgery is the primary treatment of skeletal metastases from renal cell carcinoma, because radiation and chemotherapy frequently are not effecting the survival.
Total Pancreatectomy for Metastatic Renal Cell Carcinoma with Marked Extension into the Main Pancreatic Duct
07/03/2010
The authors discuss an extremely rare case of pancreatic metastasis from RCC, with marked extension into the main pancreatic duct.
Metastatic Tumor in the Colon from Renal Cell Carcinoma
07/03/2010
The authors describe a rare case of a metastatic tumour in the colon arising from renal cell carcinoma.
Pure Sarcomatous Recurrence of Clear Cell Renal Carcinoma Following Radical Nephrectomy and Dendritic Cell Vaccination
07/03/2010
The authors discuss the patient's history and pathology images, treatments, and the potential effects of dentritic cell-tumor cell hybrid vaccination on the natural history of renal cell carcinoma.
TLN-4601
07/03/2010
TLN-4601, a small molecule derived from a nonpathogenic microorganism and TLN-232, a peptide used for the treatment of multiple oncology indications such as metastatic melanoma, renal cell carcinoma, and pancreatic cancer.
Kidney cancer patients denied drug that can extend their lives
07/02/2010
The National Institute for health and Clinical Excellence has turned down the drug called everolimus, also known as Afinitor, saying it does not offer enough benefit to patients to justify the cost.
News Feed